Clearstead Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,180
| Closed | -$40.3K | – | 2172 |
|
|
2024
Q3 | $40.3K | Hold |
2,180
| – | – | ﹤0.01% | 1251 |
|
|
2024
Q2 | $46.9K | Buy |
2,180
+60
| +3% | +$1.29K | ﹤0.01% | 1175 |
|
|
2024
Q1 | $49K | Buy |
2,120
+280
| +15% | +$6.47K | ﹤0.01% | 766 |
|
|
2023
Q4 | $55.1K | Sell |
1,840
-2,350
| -56% | -$70.4K | ﹤0.01% | 713 |
|
|
2023
Q3 | $85.9K | Buy |
4,190
+1,233
| +42% | +$25.3K | ﹤0.01% | 768 |
|
|
2023
Q2 | $58.8K | Buy |
2,957
+1,117
| +61% | +$22.2K | ﹤0.01% | 697 |
|
|
2023
Q1 | $31.5K | Buy |
+1,840
| New | +$31.5K | ﹤0.01% | 761 |
|